Max Formulations Private Limited
About Max Formulations Private Limited
Data last updated:
Max Formulations Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC138530. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26 Lakh. It is led by directors including Vaibhav Vijay Patil and Dhananjay Rajendra Kale.
Its last annual general meeting (AGM) was held on 30 September 2006, and its latest financial statements are for the year ended 31 March 2006. The registered office is at B – 24/25 Nice Areasatpur Industrial Area Nasik, Nashik, Maharashtra, India – 422007.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹87.45 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 24/25 Nice Areasatpur Industrial Area Nasik, Nashik, Maharashtra, India – 422007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Max Formulations Private Limited FY 2006 filings available
Financial Statement Summary of Max Formulations Private Limited
| Metrics | FY 2005-06 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Max Formulations Private Limited
| Metrics | FY 2005-06 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Max Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Max Formulations Private Limited
Max Formulations has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaibhav Vijay Patil | Director | 03 Jan 2003 | 23 Years 9 Months | Current |
| Dhananjay Rajendra Kale | Director | 22 Aug 2006 | 20 Years 1 Months | Current |
| Kiran Sudhakar Patil | Director | 02 Apr 2008 | 18 Years 6 Months | Current |
Charges & Borrowings of Max Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2007 | The Hongkong and Shanghai Banking Corporation | ₹2 Cr | Open |
| 22 May 2003 | Bank of India | ₹87.45 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Max Formulations Private Limited
Employment history and EPFO contributions of people linked to Max Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Max Formulations Private Limited
Max Formulations Private Limited has 3 board changes on record since 2003: 3 appointments. The latest: Kiran Sudhakar Patil was appointed as Director on 02 Apr 2008.
Credit Ratings, Litigation & Regulatory Alerts for Max Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Max Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Max Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Max Formulations Private Limited
Max Formulations has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Max Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Max Formulations Private Limited
Max Formulations is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2003 (23+ years old) and is registered under CIN U24230MH2003PTC138530.
Max Formulations has 3 current directors:
- Vaibhav Vijay Patil - Director
- Dhananjay Rajendra Kale - Director
- Kiran Sudhakar Patil - Director
No. Max Formulations has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Max Formulations is U24230MH2003PTC138530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Max Formulations was incorporated on 03 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Kiran Sudhakar Patil was appointed as Director on 02 Apr 2008. Dhananjay Rajendra Kale was appointed as Director on 22 Aug 2006. Vaibhav Vijay Patil was appointed as Director on 03 Jan 2003.
The registered office of Max Formulations is at B – 2425 Nice Areasatpur Industrial Area Nasik, Nashik, Maharashtra, India – 422007.
Max Formulations has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26 Lakh.
Max Formulations operates in the pharma industry, in the drug formulation and development segment.
No. Max Formulations is not listed on any stock exchange. It is an unlisted company.